Pharmacology: Drug Tolerance and Ion Channel Receptor Mechanisms

Overview of Drug Tolerance

• Definition: Drug tolerance refers to a diminished or reduced response to a drug following repeated administration (e.g., daily use) or prolonged exposure.

• Clinical Implications: In the presence of tolerance, an increase in the concentration or dose of the drug is required to produce the same physiological effect that was previously achieved with a lower dose.

• Scope of Development: Tolerance can occur at a molecular level (e.g., at the receptor) or at a systemic level (e.g., the respiratory system or the whole body).

Mechanisms and Timeframes of Tolerance

• Pharmacodynamic Mechanisms: These involve what the drug does to the body. This includes changes in receptor density (number) or changes in receptor function.

• Pharmacokinetic Mechanisms: These involve what the body does to the drug. This typically involves changes in the metabolism of the drug, leading to lower concentrations in the system.

• Timeframes of Development:

  • Rapid Responses: Diminished effects occurring quickly suggest mechanisms such as the depletion of neurotransmitters (e.g., noradrenaline or acetylcholine) or receptor phosphorylation.

  • Slow Responses (Days or Weeks): Diminished effects occurring over longer periods suggest changes in receptor number (internalization) or broad physiological homeostatic changes.

    • Hypothetical Case Study (Hypertension): A patient takes a drug to treat hypertension. The drug relaxes vascular smooth muscle to drop blood pressure. The body may adapt through a homeostatic mechanism by increasing salt and water retention, causing the blood pressure to rise again.

Receptor-Specific Tolerance and Desensitization

• Ion Channel Receptors: These can undergo rapid desensitization.

  • Example (Nicotinic Acetylcholine Receptor): In muscle traces, short pulses of acetylcholine at regular intervals (e.g., every five seconds) cause consistent bursts of activity. However, if the tissue is continuously exposed to acetylcholine, the sustained contraction reduces over time due to receptor tolerance. While the initial pulses still work initially, the response spikes diminish with continued exposure. This process is rapidly reversible once the bulk agonist is removed.

• G Protein-Coupled Receptors (GPCRs): These can be phosphorylated in the continued presence of a drug. Once phosphorylated, the receptor can no longer bind the drug, halting signal transduction. This happens rapidly.

• Receptor Translocation/Internalization:

  • Example (Beta-Adrenoceptor): These are normally found in the cell membrane. Continuous exposure to an agonist causes the receptor to move from the membrane to the intracellular space. Because it is no longer on the surface, it cannot bind to agonists, leading to a diminished response.

  • Biphasic Loss of Response:

    1. Phase 1: A rapid drop in response without a change in receptor density, caused by phosphorylation. This is quickly reversible.

    2. Phase 2: A gradual decrease in response corresponding to a decrease in receptor density as they are internalized. Recovery from this takes much longer after the agonist is removed.

Non-Receptor Mechanisms of Drug Tolerance

• Mediator Depletion: A mediator may be exhausted. For instance, amphetamine enters nerve terminals to release noradrenaline. After continuous use, noradrenaline stores are depleted, reducing the drug's effect.

• Altered Metabolism: Chronic use of substances like ethanol or barbiturates induces higher enzyme activity or increased enzyme production. This results in the drug being metabolized more effectively, leading to lower blood concentrations and reduced effects.

• Physiological Adaptation (Homeostasis): The body attempts to return to a set point. For example, thiazide diuretics lower blood pressure by producing more urine and reducing blood volume. However, this may trigger the renin-angiotensin system, which counters the drop in pressure.

• Active Efflux in Cancer Chemotherapy: Cancer cells can develop tolerance by actively extruding or expelling chemotherapy drugs using cellular pumps to prevent the drugs from killing the cell.

The Four Receptor Superfamilies

• Ion Channel Receptors (Ionotropic): These are linked to ion channels. When activated by an agonist, the channel opens, changing membrane potential through conductance. These are the fastest-acting receptors.

• G Protein-Coupled Receptors (Metabotropic): These involve one or more metabolic steps. They may be linked to ion channels (changing membrane excitability), second messenger generation, or protein phosphorylation.

• Enzyme-Linked Receptors: These are linked to enzyme activity. Activation leads to protein phosphorylation and protein synthesis.

• Nuclear/Intracellular Receptors: These are linked to DNA. Their activation regulates gene transcription and protein synthesis.

Principles of Ion Channels and Membrane Potential

• Ion Channel Fundamentals:

  • Ligand-Gated Ion Channels: Also known as ion channel receptors; they open/close when an agonist binds to them.

  • Voltage-Gated Ion Channels: These open and close based on the membrane potential.

  • Second Messenger Regulated Ion Channels: These are typically linked to GPCRs.

• Role of the Cell Membrane: The membrane is a lipid bilayer that charged ions cannot cross without a channel.

• Resting Membrane Potential: Cells maintain a negative internal potential between $-30\,mV$ and $-80\,mV$ at rest.

• Membrane Polarization States:

  • Depolarization: Positive ions (e.g., $Na^+$) enter the cell, making the potential more positive (e.g., $-70\,mV \rightarrow -50\,mV$). This leads to excitatory responses like muscle contraction or nerve firing.

  • Hyperpolarization: Negative ions (e.g., $Cl^-$) enter the cell, making the potential more negative. This makes the cell less likely to fire or contract (inhibitory response).

• Electrochemical Gradient: The rate and direction of ion movement depend on concentration gradients (moving from high to low) and electrical charge (opposites attract).

• Selectivity: Channels are selective based on size and lining charge. A channel lined with positive charges will attract negative ions through it.

Analytical Techniques: Patch Clamp Recording

• Function: Patch clamp recording measures very small current changes across a membrane in the picoamp range ($10^{-12}\,A$).

• Process: A micropipette is held against a cell membrane to isolate a small "patch." In an "inside-out" patch, the membrane is pulled off so the inside of the cell faces the outside buffer.

• Observations: Receptors do not stay open; they exhibit repeated channel openings. For example, if a recording shows steps of $1.5\,pA$ and climbs to $3\,pA$, this suggests the presence of two channels in that specific patch.

Structural Analysis of Ion Channel Receptors

• Composition: These receptors consist of four or five membrane-spanning protein subunits (named $\alpha, \beta, \gamma, \delta$, etc.).

• Subunit Role: The specific subunits determine the physiological properties (which ions pass) and pharmacological properties (which drugs bind).

• Molecular Structure: Each subunit has an N and C terminus located extracellularly. Transmembrane domains are often alpha helices.

• Nicotinic Acetylcholine Receptor (nAChR): Features five subunits, including two alpha subunits. The binding site for acetylcholine is located on the alpha subunits. When two molecules of agonist bind, the subunits rotate slightly to open the center channel.

Key Transmitters and Modulators

• Acetylcholine (ACh): An excitatory neurotransmitter. It stimulates nAChRs, allowing $Na^+$ to enter the cell and cause depolarization. It is found at the skeletal neuromuscular junction, CNS, and PNS.

• Gamma-Aminobutyric Acid (GABA): Formed from glutamate in the brain. It is the primary inhibitory neurotransmitter in the CNS.

  • GABA A Receptors: Ion channel receptors that allow $Cl^-$ influx, leading to hyperpolarization.

• Glycine: An amino acid and inhibitory neurotransmitter in the CNS and spinal cord.

  • Strychnine: A poison that acts as a surmountable antagonist at glycine receptors. By blocking inhibition/glycine, it leads to convulsions and muscle contractions.

• Glutamate: An amino acid acting as a fast-acting excitatory neurotransmitter in the CNS.

• Serotonin (5-Hydroxytryptamine / 5-HT): Acts on multiple receptor types, including ion channels. Involved in gut function, vascular relaxation, and blood clotting (platelet aggregation).

Anatomy and Pharmacology of the Neuromuscular Junction (NMJ)

• Structure: The junction between a motor nerve and a skeletal muscle fiber is the motor end plate.

  • Presynaptic Boutons: Button-like structures at the end of the axon that increase surface area for neurotransmitter release.

  • Synaptic Cleft: The gray space between the presynaptic nerve and postsynaptic muscle.

  • Myelin: An insulator secreted by Schwann cells that speeds up nerve impulse transmission.

• Mechanism of Contraction:

  1. A nerve impulse arrives at the terminal.

  2. Synaptic vesicles release acetylcholine into the cleft.

  3. ACh binds to nAChRs on the muscle, causing repeated channel openings and local depolarization.

  4. This triggers nearby voltage-gated ion channels to open.

  5. A massive influx of $Na^+$ occurs, reaching the threshold for muscle contraction.

• Pharmacological Agents at the NMJ:

  • Pancuronium: A surmountable antagonist (found in Curare). It competes with ACh for the receptor but does not open the channel. Used in surgery to prevent muscle twitching by causing paralysis.

  • Suximethonium: A long-acting agonist. Unlike the short-acting ACh, suximethonium keeps the channel open, preventing the repetitive depolarizations needed for voltage-gated channels to function. This causes a neuromuscular block. It is used clinically for short-term paralysis during tracheal intubation.

Questions & Discussion

Topic: Matching Physiological Responses to Receptor Superfamilies and Speeds

• Control of blood glucose after a meal:

  • Receptor: Insulin receptor.

  • Superfamily: Enzyme-linked receptor.

  • Speed: Minutes.

• Dilation of the airway in the lung via adrenaline/salbutamol:

  • Receptor: $\beta_2$-adrenoceptor.

  • Superfamily: G protein-coupled receptor.

  • Speed: Seconds to minutes.

• Protein synthesis caused by hydrocortisone:

  • Receptor: Glucocorticoid receptor (Nuclear receptor).

  • Superfamily: Nuclear receptors.

  • Speed: Hours (the slowest response).

• Response of the brain to an emergency:

  • Superfamily: Ion channel receptors.

  • Speed: Milliseconds (very fast).

• Twitch of skeletal muscle in response to acetylcholine:

  • Receptor: Nicotinic acetylcholine receptor.

  • Superfamily: Ion channel receptors.

  • Speed: Milliseconds.